Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new “virtual biopsy” device that can quickly determine a skin lesion’s depth and potential malignancy without using a scalpel.
The ability to analyze a skin tumor non-invasively could make biopsies much less risky and distressing to patients, according to a report in Wiley Online Library. Currently, physicians who perform surgical biopsies often don’t know the extent of a lesion – and whether it will be necessary to refer the patient to a specialist for extensive tissue removal or plastic surgery – until surgery has already begun.
The first-of-its-kind experimental procedure, called vibrational optical coherence tomography (VOCT), creates a 3-D map of the legion’s width and depth under the skin with a tiny laser diode. It also uses soundwaves to test the lesion’s density and stiffness since cancer cells are stiffer than healthy cells. An inch-long speaker applies audible soundwaves against the skin to measure the skin’s vibrations and determine whether the lesion is malignant.
“This procedure can be completed in 15 minutes with no discomfort to the patient, who feels no sensation from the light or the nearly inaudible sound. It’s a significant improvement over surgical biopsies, which are invasive, expensive and time consuming,” said lead researcher Frederick Silver, a professor of pathology and laboratory medicine at Rutgers Robert Wood Johnson Medical School.
The study found that a prototype VOCT device, which awaits FDA approval for large-scale testing, is able to accurately distinguish between healthy skin and different types of skin lesions and carcinomas. The researchers tested the device over six months on four skin excisions and on eight volunteers without skin lesions. Further studies are needed to fine-tune the device’s ability to identify a lesion’s borders and areas of greatest density and stiffness, which would allow physicians to remove tumors with minimally invasive surgery.
The Latest on: Non-invasive biopsy
via Google News
The Latest on: Non-invasive biopsy
- Blood Biomarkers Could Help Diagnose Sarcoids in Horseson June 28, 2019 at 5:29 am
The study, “MicroRNA fingerprints in serum and whole blood of sarcoid-affected horses as potential non-invasive diagnostic biomarkers,” was published in Veterinary and Comparative Oncology. ... […]
- Power Doppler ultrasound and contrast-enhanced ultrasound demonstrateon June 27, 2019 at 3:48 pm
However, in addition to tissue biopsy being an invasive monitoring technique ... Considering the US results of this study, the clinical value of this non-invasive modality warrants further exploration ... […]
- OncoCyte Provides Mid-Year Updateon June 26, 2019 at 7:05 am
About OncoCyte Corporation OncoCyte is focused on the development and commercialization of novel, non-invasive blood ("liquid biopsy") diagnostic tests for the early detection of cancer. Early ... […]
- Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.on June 24, 2019 at 10:15 pm
announces that it has successfully closed the acquisition of Transplant Genomics Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial ... […]
- Non-invasive, more precise preimplantation genetic test under development for IVF embryoson June 24, 2019 at 12:04 pm
Since it is non-invasive, it does not interfere directly ... Each blastocyst had previously undergone TE biopsy testing by an outside laboratory. The investigators compared the sequencing results ... […]
- Global Fluid Biopsy Market Report 2019-2024 - Major Players are Bio-Rad Labs, LungLife AI (Cynvenio), Guardant Health, Horizon Discovery, and Qiagen -on June 21, 2019 at 10:06 am
DUBLIN--(BUSINESS WIRE)--The "Fluid Biopsy Market - Growth ... In 2016, an estimated 246,660 new cases of invasive breast cancer and 61,000 new cases of non-invasive (in situ) breast cancer were ... […]
- Insights Into the World Fluid Biopsy Market (2019-2024): Breast Cancer Expected to Grow with a High CAGRon June 21, 2019 at 7:33 am
In 2016, an estimated 246,660 new cases of invasive breast cancer and 61,000 new cases of non-invasive (in situ ... Early detection and treatment reduce the mortality rate. A biopsy is the only ... […]
- Biomarkers Being Identified for Improved Diagnosis of Nasopharyngeal Carcinoma Via Liquid Biopsyon June 21, 2019 at 6:14 am
So, that's why we believe that there's an unmet need for non-invasive tests like liquid biopsy. And that’s why we have some expertise in the field of DNA methylation, and we have already established ... […]
- Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023on June 13, 2019 at 1:38 pm
When compared with conventional tissue biopsy, liquid biopsy tests address a significant medical need: a biopsy that is non-invasive and has little or no risk of medical complications.The validation ... […]
- OncoCyte to be Added to the Russell 2000®, 3000® and Microcap Indexeson June 11, 2019 at 5:10 am
DetermaVu™ is a trademark of OncoCyte Corporation About OncoCyte Corporation OncoCyte is focused on the development and commercialization of novel, non-invasive blood ("liquid biopsy") diagnostic ... […]
via Bing News